Instil Bio Inc. Common Stock (TIL)
Stock · NASDAQ · Health Care
$5.96as of 10/16/2026
Price chart
Active signals
TIL Signal Track Record
How signals performed across all stocks →What TIL's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 41 | -7.1% | 34% | October 8, 2026 |
| Bollinger Band BreakdownActive now | 20 | -3.7% | 40% | October 8, 2026 |
| Bollinger Band Breakout | 19 | -8.3% | 32% | August 24, 2026 |
| 200-Day Moving Average TouchActive now | 5 | +19.8% | 60% | June 25, 2025 |
| Any 20-session window (baseline) | -5.9% | 33% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About TIL
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 17
- Website
- instilbio.com/
Fundamentals
- 1-day range
- $5.91$6.45
- Market cap
- $49.37M
- P/E (trailing)
- —
- P/E (forward)
- -0.40
- EPS (trailing)
- $-4.47
- Dividend yield
- —
- Beta
- 1.90
- Avg. volume
- 13.9K
Forecasts
1 analyst ratings
Instil Bio Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- TILInstil Bio Inc. Common Stock$5.91▼ 3.59%Market cap $49.37MP/E —$5.67$21.64
- ATYRaTyr Pharma Inc. Common Stock$0.174▼ 5.43%Market cap $49.22MP/E —$0.2$1.11
- TCRXTScan Therapeutics Inc. Common Stock$0.231▼ 3.35%Market cap $49.88MP/E —$0.2243$2.57
- INMBINmune Bio Inc. Common stock$1.57▼ 4.85%Market cap $50.78MP/E —$1.09$2.6
- EXOZeXoZymes Inc. Common Stock$4.09▲ 2.25%Market cap $47.57MP/E —$4.35$18.4
- OKYOOKYO Pharma Limited Ordinary Shares$1.41▼ 1.40%Market cap $51.94MP/E —$1.26$3.2
- MGXMetagenomi Therapeutics Inc. Common Stock$0.784▼ 7.22%Market cap $46.68MP/E —$0.86$3.95
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| TIL Instil Bio Inc. Common Stock | $49.37M | — | $5.91 | ▼ 3.59% | $5.67$21.64 |
| ATYR aTyr Pharma Inc. Common Stock | $49.22M | — | $0.174 | ▼ 5.43% | $0.2$1.11 |
| TCRX TScan Therapeutics Inc. Common Stock | $49.88M | — | $0.231 | ▼ 3.35% | $0.2243$2.57 |
| INMB INmune Bio Inc. Common stock | $50.78M | — | $1.57 | ▼ 4.85% | $1.09$2.6 |
| EXOZ eXoZymes Inc. Common Stock | $47.57M | — | $4.09 | ▲ 2.25% | $4.35$18.4 |
| OKYO OKYO Pharma Limited Ordinary Shares | $51.94M | — | $1.41 | ▼ 1.40% | $1.26$3.2 |
| MGX Metagenomi Therapeutics Inc. Common Stock | $46.68M | — | $0.784 | ▼ 7.22% | $0.86$3.95 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- R. Kent McGaughy Jr. · June 11, 2026 · Grant6.5K
- Matcham George · June 11, 2026 · Grant6.5K
- Gwendolyn Binder · June 11, 2026 · Grant6.5K
- Gibson Neil W · June 11, 2026 · Grant0
Institutional Ownership
March 31, 2026
- Total shares held
- 2.23M
- Total value held
- $18.30M
- Institutional holders
- 29
- Unknown645.6K
- Unknown410.9K
- Unknown292.7K
- Unknown174.6K
- Unknown139.8K
- Unknown132.9K
- Unknown59.1K
- Unknown52.0K
- Unknown50.0K
- Unknown49.0K
See the full, filterable feed with live charts on the MarketWall dashboard.